companydata.dkcompanydata.dk

NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2014

CVR: 34352542

Source: annual report 2014, Danish Business Authority

01/07/2013 – 30/06/2014

NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 8,018,461 and a net result of DKK 3,312,590 compared with DKK 1,026,917 the year before. That is an increase of 46.3% compared with the year before. Equity in the 2014 report amounted to DKK 2,512,590. The solvency ratio was 43.4%.

Gross Profit
DKK 8,018,461
Profit/Loss
DKK 3,312,590
Equity
DKK 2,512,590
Total Assets
DKK 5,788,645

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-8M3.3M2.5M-
2013-5.5M1M1.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

NORDIC MEDICAL SOLUTIONS ApS appoints new auditorDec 15, 2014

As of December 15, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC MEDICAL SOLUTIONS ApS.

Auditor steps down at NORDIC MEDICAL SOLUTIONS ApSDec 15, 2014

As of December 15, 2014, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of NORDIC MEDICAL SOLUTIONS ApS.

About NORDIC MEDICAL SOLUTIONS ApS

NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.

Source: annual report 2026, Danish Business Authority